Pittsburgh, PA, United States of America

Jagannath Panda

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Pittsburgh. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jagannath Panda. Retrieved from https://idiyas.com/inventor/jagannath-panda-qu3az76x

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jagannath Panda: Innovator in Pharmaceutical Compounds

Introduction

Jagannath Panda is a notable inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can treat serious medical conditions. His work is characterized by a focus on innovative solutions to pressing health issues.

Latest Patents

Jagannath Panda holds a patent for "Substituted indoles with inhibitory activity." This patent discloses substituted indole compounds and compositions that can be utilized for treating or preventing acute renal failure in a subject. Additionally, these compounds and compositions have potential applications in treating infectious diseases or cancer. His innovative approach in this area has the potential to impact many lives positively.

Career Highlights

Panda is affiliated with the University of Pittsburgh, where he conducts research and develops new pharmaceutical compounds. His work at the university has allowed him to explore various aspects of medicinal chemistry and contribute to advancements in healthcare.

Collaborations

Jagannath Panda collaborates with Neil Hukriede, enhancing the research efforts in their field. Their partnership exemplifies the importance of teamwork in scientific research and innovation.

Conclusion

Jagannath Panda's contributions to pharmaceutical innovations demonstrate his commitment to improving health outcomes through research and development. His patent on substituted indoles highlights the potential for new treatments in critical areas of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…